Anzeige
Mehr »
Login
Donnerstag, 23.01.2025 Börsentäglich über 12.000 News von 682 internationalen Medien
Amazon investiert Millionen in Kernenergie - so können Sie sich früh positionieren!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A40P0G | ISIN: US76090R3093 | Ticker-Symbol: 24O
NASDAQ
22.01.25
16:33 Uhr
4,220 US-Dollar
0,000
0,00 %
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
RESHAPE LIFESCIENCES INC Chart 1 Jahr
5-Tage-Chart
RESHAPE LIFESCIENCES INC 5-Tage-Chart

Aktuelle News zur RESHAPE LIFESCIENCES Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DiReShape Lifesciences Inc. - 8-K, Current Report-
DiReShape Lifesciences Inc. - S-1, General form for registration of securities-
15.01.ReShape Lifesciences Inc. - S-4/A, Registration of securities, business combinations-
15.01.ReShape Lifesciences Inc. - S-1/A, General form for registration of securities-
13.01.ReShape Lifesciences Inc: ReShape Lifesciences Provides Update on Merger Agreement With Vyome Therapeutics and Asset Purchase Agreement With Biorad Medisys76IRVINE, Calif. and CAMBRIDGE, Mass., Jan. 13, 2025 (GLOBE NEWSWIRE) -- ReShape Lifesciences Inc. (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health-solutions company, and Vyome...
► Artikel lesen
27.12.24ReShape Lifesciences Inc. - 8-K, Current Report-
20.12.24ReShape Lifesciences files to sell up to 2.11M shares for holder2
20.12.24ReShape Lifesciences Inc. - S-1, General form for registration of securities-
RESHAPE LIFESCIENCES Aktie jetzt für 0€ handeln
11.12.24RSLS-Aktie erreicht 52-Wochen-Tief bei 4,48 US-Dollar2
06.12.24ReShape Lifesciences Inc. - S-4/A, Registration of securities, business combinations-
02.12.24ReShape Lifesciences Inc. - 8-K, Current Report-
14.11.24ReShape Lifesciences Inc. - 8-K, Current Report-
12.11.24ReShape Lifesciences Inc: ReShape Lifesciences to Announce Financial Results for the Third Quarter Ended September 30, 2024, and Provide Corporate Update2
12.11.24ReShape Lifesciences Inc: ReShape Lifesciences Receives Health Canada Approval for its Next-Generation Lap-Band 2.0 FLEX603IRVINE, Calif., Nov. 12, 2024 (GLOBE NEWSWIRE) -- ReShape Lifesciences® (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced that Health Canada...
► Artikel lesen
11.11.24ReShape Lifesciences Inc: ReShape Lifesciences Receives NIH Supplementary Grant with the University of Southern California's Center for Autonomic Nerve Recording and Stimulation Systems (CARSS) to Further Develop Next-Generation Electrodes ...1
17.10.24ReShape Lifesciences Inc. - 8-K, Current Report3
02.10.24RSLS stock touches 52-week low at $4.99 amid market challenges4
01.10.24ReShape Lifesciences Inc. - S-4, Registration of securities, business combinations1
19.09.24ReShape Lifesciences announces 1-for-58 reverse stock split2
19.09.24ReShape Lifesciences kündigt Aktienzusammenlegung im Verhältnis 1:58 an3
Seite:  Weiter >>
34 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1